Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
11%
Ph phase_2
1
11%
Ph phase_4
1
11%
Ph not_applicable
4
44%
Ph early_phase_1
1
11%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
4(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(6)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (12.5%)
Phase 11 (12.5%)
Phase 21 (12.5%)
Phase 41 (12.5%)
N/A4 (50.0%)

Trials by Status

completed667%
recruiting111%
unknown222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9